Evidence map›Paper›PMID 22719854›Full record

ArticlePloS one2012

A novel pathway regulates thyroid hormone availability in rat and human hypothalamic neurosecretory neurons.

Imre Kalló, Petra Mohácsik, Barbara Vida, Anikó Zeöld, Zsuzsanna Bardóczi, Ann Marie Zavacki, Erzsébet Farkas, Andrea Kádár, Erik Hrabovszky, Rafael Arrojo E Drigo and 10 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Advances in TRH signaling.Reviews in endocrine & metabolic disorders · 2016
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Defending plasma T3 is a biological priority.Clinical endocrinology · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Imre KallóDepartment of Endocrine Neurobiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary.
Petra Mohácsik
Barbara Vida
Anikó Zeöld
Zsuzsanna Bardóczi
Ann Marie Zavacki
Erzsébet Farkas
Andrea Kádár
Erik Hrabovszky
Rafael Arrojo E Drigo
Liping Dong
László Barna
Miklós Palkovits
Beáta A Borsay
László Herczeg
Ronald M Lechan
Antonio C Bianco
Zsolt Liposits
Csaba Fekete
Balázs Gereben
Hungarian Academy of Sciences · HUHUN-REN Institute of Experimental Medicine · HUUniversity of Miami · USUniversity of Debrecen · HUHarvard University · USSemmelweis University · HUTufts Medical Center · US

Funding

Metabolic and Xenobiotic Control of Thyroid Hormone MetabolismR01DK077148 · NIDDK · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ANTONIO C BIANCO · 2007 to 2026
$4.5M
NIDDK NIH HHS R01 DK077148
6 · The paper itself

Abstract

Hypothalamic neurosecretory systems are fundamental regulatory circuits influenced by thyroid hormone. Monocarboxylate-transporter-8 (MCT8)-mediated uptake of thyroid hormone followed by type 3 deiodinase (D3)-catalyzed inactivation represent limiting regulatory factors of neuronal T3 availability. In the present study we addressed the localization and subcellular distribution of D3 and MCT8 in neurosecretory neurons and addressed D3 function in their axons. Intense D3-immunoreactivity was observed in axon varicosities in the external zone of the rat median eminence and the neurohaemal zone of the human infundibulum containing axon terminals of hypophysiotropic parvocellular neurons. Immuno-electronmicroscopy localized D3 to dense-core vesicles in hypophysiotropic axon varicosities. N-STORM-superresolution-microscopy detected the active center containing C-terminus of D3 at the outer surface of these organelles. Double-labeling immunofluorescent confocal microscopy revealed that D3 is present in the majority of GnRH, CRH and GHRH axons but only in a minority of TRH axons, while absent from somatostatin-containing neurons. Bimolecular-Fluorescence-Complementation identified D3 homodimers, a prerequisite for D3 activity, in processes of GT1-7 cells. Furthermore, T3-inducible D3 catalytic activity was detected in the rat median eminence. Triple-labeling immunofluorescence and immuno-electronmicroscopy revealed the presence of MCT8 on the surface of the vast majority of all types of hypophysiotropic terminals. The presence of MCT8 was also demonstrated on the axon terminals in the neurohaemal zone of the human infundibulum. The unexpected role of hypophysiotropic axons in fine-tuned regulation of T3 availability in these cells via MCT8-mediated transport and D3-catalyzed inactivation may represent a novel regulatory core mechanism for metabolism, growth, stress and reproduction in rodents and humans.

Indexed as

AnimalsAxonsFluorescent Antibody TechniqueHumansHypothalamusImmunohistochemistryMaleNeuronsRatsRats, WistarReverse Transcriptase Polymerase Chain ReactionThyroid HormonesThyroid Hormones

Identifiers

PMID22719854
PMCPMC3377717
OpenAlexW2038334005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.